Tech Review has an article on Oxford Nanopore Technologies, one of the newest next-gen sequencing companies to enter the race for the $1000 genome. Because nanopore sequencing can analyze individual strands of DNA, the process saves time and money on sample prep. "We think we're the only label-free technology out there," Gordon Sanghera says. "There's no labeling. There's no amplification.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.